Opioid- and stimulant-related harms in Canada
Presented here are the most recent available data on overdoses and deaths involving opioids and/or stimulants from January 2016 to March 2024 in Canada, where available.
Background information on HIV, hepatitis C and STIs in Canada, including basic information, statistics (epidemiology), provincial and national strategies to address HIV, hepatitis C and STIs, and social determinants of health.
Information on HIV and hepatitis C transmission and prevention, including STIs and safer sex, harm reduction, pregnancy and infant feeding, and microbicides and vaccines.
Information on diagnostic tests for HIV, hepatitis C and STIs; the delivery of testing and counselling; and resources for people who are newly diagnosed.
Information on treatment, care and support for HIV, hepatitis C and STIs, including medications, healthy living, pregnancy and infant feeding, hepatitis C re-infection, and long-term health issues.
CATIE’s online educational courses, webinars, online and print publications, and other websites.
CATIE strengthens Canada’s response to HIV and hepatitis C by bridging research and practice. We connect healthcare and community-based service providers with the latest science, and promote good practices for prevention and treatment programs.
Presented here are the most recent available data on overdoses and deaths involving opioids and/or stimulants from January 2016 to March 2024 in Canada, where available.